Rankings
▼
Calendar
ACET FY 2010 Earnings — Adicet Bio, Inc. Revenue & Financial Results | Market Cap Arena
ACET
Adicet Bio, Inc.
$68M
FY 2010 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$347M
+7.4% YoY
Gross Profit
$54M
15.6% margin
Operating Income
$9M
2.7% margin
Net Income
$7M
1.9% margin
EPS (Diluted)
$4.80
Cash Flow
Operating Cash Flow
-$15M
Free Cash Flow
-$19M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$217M
Total Liabilities
$92M
Stockholders' Equity
$140M
Cash & Equivalents
$31M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$347M
$323M
+7.4%
Gross Profit
$54M
$56M
-2.6%
Operating Income
$9M
$12M
-20.6%
Net Income
$7M
$9M
-23.7%
← FY 2009
All Quarters
FY 2011 →